Abstract: To provide a toner for developing a latent electrostatic image comprising at least a colorant, a wax, and a binder resin, wherein Iwax (s) is a value measured by FTIR-ATR Spectroscopy before heating a mirror-surfaced pellet formed by compressing and molding the toner, and Iwax (t) is a value measured by FTIR-ATR Spectroscopy after heating the pellet at a surface temperature thereof of 130° C. for 1 minute satisfy Formulae (1), (2), (3), and (4), Iwax (t)?0.2*100/[T½(° C.)]??Formula (1) Iwax (s)?0.26??Formula (2) Iwax (t)?0.50??Formula (3) Iwax (t)>Iwax (s)??Formula (4) wherein both Iwax(s) and Iwax(t) are obtained by a formula: absorbance derived from the wax (2850 cm?1)/absorbance derived from the binder resin (828 cm?1).

Abstract: The invention provides a composition for preventing or treating infectious diseases of a virus belonging to the Coronavirus family or Flavivirus family, the composition containing one or more substances selected from reduced glutathione or oxidized glutathione or pharmaceutically acceptable salts thereof and catechin, and a composition for preventing or treating infectious diseases of a virus belonging to the Coronavirus family or Flavivirus family, the composition containing reduced glutathione or oxidized glutathione or pharmaceutically acceptable salts thereof and catechin.

Abstract: The present invention relates to an image-forming method and a image-forming device, wherein a specific photosensitive member, an exposing process and a toner are adopted in combination.

Abstract: The present invention relates to an image-forming method and a image-forming device, wherein a specific photosensitive member, an exposing process and a toner are adopted in combination.

Abstract: Disclosed is a liquid crystal display apparatus comprising a pair of substrates and a liquid crystal layer provided between the substrates, the liquid crystal layer containing a liquid crystal composition that exhibits a cholesteric phase. The liquid crystal composition contains a mixture of a chiral material and nematic liquid crystal. The liquid crystal display layer is configured to satisfies the following conditions: a viscosity a [cP] of the liquid crystal composition is in a range from 30 to 150; a dielectric anisotropy b of the liquid crystal composition is in a range from 5 to 50; a thickness c [?m] of the liquid crystal layer is in a range from 3 to 8; and a product of a, b, and c is not less than 3500.

Abstract: A liquid crystal element of a layered type capable of high contrast is provided. For example, in the liquid crystal element of the layered type including liquid crystal layers b, g and r in this order, each of the liquid crystal layers b, g and r is held between electrode formation surfaces of a pair of substrates each provided with an electrode, an insulating film is disposed between the electrodes of the substrates, and at least two liquid crystal layers of the liquid crystal layers b, g and r have the insulating films opposed to the liquid crystal layers and being different in refractive index from each other, respectively.

Abstract: The present invention relates to an image-forming method and a image-forming device, wherein a specific photosensitive member, an exposing process and a toner are adopted in combination.

Abstract: A liquid crystal display element includes a cholesteric phase liquid crystal component and a space holding member held within a pair of substrates, wherein at least one of which is transparent. The liquid crystal component is a chiral-nematic liquid crystal material containing a liquid crystal pyrimidine compound having fluorine in the molecule, liquid crystal diphenylacetylene having fluorine in the molecule, and a chiral component. The liquid crystal component may also contain a liquid crystal phenylcyclohexane compound, a liquid crystal cyanobiphenyl compound, and a liquid crystal alkenyl compound. In the present invention, characteristics such as color purity and reflectivity are improved, contrast is increased, and the drive voltage can be reduced by including in the nematic liquid crystal component a liquid crystal pyrimidine compound having fluorine within the molecule, and a liquid crystal diphenylacetylene compound containing fluorine within the molecule.

Abstract: Disclosed is a liquid crystal display apparatus comprising a pair of substrates and a liquid crystal layer provided between the substrates, the liquid crystal layer containing a liquid crystal composition that exhibits a cholesteric phase. The liquid crystal composition contains a mixture of a chiral material and nematic liquid crystal.

Abstract: A medicinal composition comprising a practically water-insoluble anthelmintic compound such as PF1022 substance, which is a cyclic depsipeptide compound, as an active ingredient, and one or more compounds selected from either or both of nonionic surfactants and fats and oils, optionally together with one or more aqueous solvents, wherein the total content of the additives is adjusted to not less than 1 part by weight, preferably from 5 to 50 parts by weight, based on the anthelmintic compound. This composition makes it possible to elevate water-solubility of the anthelmintic comopund and thus enhance its anthelmintic effect.